Why Van Westendorp Analysis Matters in MedTech
In MedTech, pricing decisions are rarely straightforward. Different stakeholders view price through different lenses — clinicians focus on outcomes and usability, procurement on cost and value. Pricing is ultimately a balance across these perspectives. Van Westendorp helps answer a key early question: are we even in the right pricing range?
Rather than defining an exact price, it reveals how price is interpreted — when it signals low quality, when it feels acceptable, and when it starts to create resistance that could limit adoption.
This makes it particularly valuable in early-stage medical device pricing research, where assumptions are often untested. It provides a clear starting point by establishing a credible pricing corridor, helping ensure pricing is aligned with how the market perceives value.
Van Westendorp helps quantify:
How price signals value and risk
Understanding when pricing reinforces credibility versus raising concerns about quality or cost.
Where pricing may restrict adoption
Identifying thresholds where stakeholders begin to reject the product on price alone.
Where opportunities exist to differentiate and reposition
Highlighting gaps in the market and areas where new or existing products can stand out.
This creates a strong foundation for further medical device pricing analysis, but not a final answer.